Harvard Bioscience Inc (HBIO): Operating Income
-$48.58M
Year ended 2025-12-31
-$245.0K
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$48.58M | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$6.21M | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $1.89M | n/m | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | -$6.93M | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $2.07M | +834.8% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $221.0K | -41.4% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $377.0K | -61.7% | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | $984.0K | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$635.0K | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$3.00M | n/m | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | -$1.71M | n/m | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $6.62M | +330.6% | 2017-03-17, From 2014-01-01 |
| 2013-12-31 | $1.54M | -80.4% | 2016-04-29, From 2013-01-01 |
| 2012-12-31 | $7.83M | -6.8% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $8.40M | n/c | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | $10.22M | +26.9% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $8.05M | n/a | 2012-03-15, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | -$48.58M | n/m |
| 908 Devices Inc. (MASS) | 2025-12-31 | -$39.42M | n/m |
| Quanterix Corp (QTRX) | 2025-12-31 | -$125.54M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$553.86M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$40.38M | n/m |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$47.39M | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$243.43M | n/m |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$33.34M | n/m |
| Precipio, Inc. (PRPO) | 2025-12-31 | -$1.20M | n/m |
Compare HBIO, MASS, QTRX, PACB side by side · Screen every company in Laboratory Analytical Instruments ↗